Open Label, Single Dose, Non-randomized Study to Assess the Drug to Drug Interaction of Briakinumab on CYP Substrates.

Clinical trial NCT01260844 · WITHDRAWN

Trial details

NCT number: NCT01260844
Sponsor: Abbott
Status: WITHDRAWN
Phase: Phase 1
Study type: INTERVENTIONAL

Moderate to Severe Plaque Psoriasis

Start date: 2011-04-01
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.